Skip to main navigation Skip to search Skip to main content

Apigenin as a potential modulator of neuroinflammation in multiple sclerosis: a review

  • Monique Reis de Santana
  • , Nívia Nonato Silva
  • , Juciele Valéria Ribeiro de Oliveira
  • , Mauricio Moraes Victor
  • , Arthur Morgan Butt
  • , Silvia Lima Costa

Research output: Contribution to journal › Article › peer-review

5 Downloads (Pure)

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) characterized by neuroinflammation and demyelination. Although treatment options for MS have increased over the past decade, current therapies primarily target the peripheral immune system and are often associated with significant side effects. Moreover, these therapies still do not offer solutions for the resulting neurodegeneration that accompanies the progression of the disease. Findings from research using cellular and animal models and studies in humans highlight the neuroprotective and anti-inflammatory properties of apigenin, a flavonoid present in several commonly consumed plant species, such as cabbage, orange, tea, onion, and chamomile. This review compiles chemical and current evidence on the therapeutic potential of apigenin, primarily on its ability to modulate neuroinflammation and underscore the need for further investigation into its clinical applications as an adjuvant therapy for MS.
Original languageEnglish
Article number1545
Number of pages26
JournalBiology
Volume15
Issue number17
DOIs
Publication statusPublished - 1 Sept 2026

Keywords

  • apigenin
  • neuroinflammation
  • multiple sclerosis
  • experimental autoimmune encephalomyelitis
  • flavonoid
  • neuroprotection

Fingerprint

Dive into the research topics of 'Apigenin as a potential modulator of neuroinflammation in multiple sclerosis: a review'. Together they form a unique fingerprint.

Cite this